Trial Profile
A phase II trial of blinatumomab in mantle cell lymphoma.
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 08 Dec 2010
Price :
$35
*
At a glance
- Drugs Blinatumomab (Primary)
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- 08 Dec 2010 New trial record